Ketamine Safety and Side Effects

Ketamine has been used in medicine for decades, and its effects at the doses used in therapy are well characterized. That does not make it risk-free. This page lays out the common side effects, the less common concerns, who should not receive ketamine, and the safeguards a supervised clinic should have in place.

Two things can be true at once: ketamine therapy can be delivered responsibly, and it demands respect. We would rather give you an honest accounting here than a reassuring one.

Most side effects appear during or shortly after a session and fade as the medicine wears off, typically within hours. The most common is dissociation — a temporary sense of detachment from your body or surroundings — along with nausea, dizziness, and blurred vision.

Ketamine also commonly raises blood pressure and heart rate for a short period, which is one reason sessions happen with monitoring equipment in place. Some people feel tired or mildly off-balance for the rest of the day, which is why you rest after a session and do not drive until the next day.

Less commonly, people experience anxiety or distress during a session, headaches, or lingering nausea. Serious reactions are uncommon in screened, monitored settings, but they are exactly what screening and monitoring exist to catch.

You may have read about bladder damage or memory problems linked to ketamine. Those harms are documented primarily in people who misuse ketamine chronically — frequently, at high doses, and without medical supervision. That pattern is fundamentally different from a supervised course of therapy with clinical dosing, and we still take the concern seriously: screening, controlled dosing, and deliberate spacing between sessions are part of how a responsible clinic keeps therapeutic use from drifting toward misuse.

The FDA has warned patients and health care providers about potential risks associated with compounded ketamine products, particularly products used at home without in-person monitoring. The concern is straightforward: without screening, supervision, and monitoring, side effects that are manageable in a clinic can become dangerous outside one.

For clarity on the regulatory landscape: ketamine is FDA-approved as an anesthetic. It is not FDA-approved for depression, PTSD, anxiety, or chronic pain — those uses are off-label. Esketamine (Spravato), a related nasal spray, is FDA-approved for specific depression indications and is dispensed only through a restricted federal program with mandatory observation. Off-label prescribing is legal and common in medicine, but it places more responsibility on the clinic to screen and monitor well.

Ketamine is not appropriate for everyone. Certain situations — including uncontrolled high blood pressure, certain heart conditions, active psychosis, pregnancy, and certain substance-use histories — may rule out treatment. That call is made by the evaluating clinicians after reviewing your full history, never by a web page.

If any of these apply to you, it does not automatically mean treatment is impossible; it means the conversation with the clinical team matters more. Raise it early, and never minimize a health condition in order to qualify.

Monitoring starts before the first session, with a full medical and psychiatric screening. During each session, a clinician tracks your vital signs and stays attentive to how you are doing. Afterward, you remain in the clinic until the immediate effects have worn off and it is safe to leave with your arranged ride.

Between sessions, we check in and track how you are responding against the goals set at the start. If side effects become a problem, or treatment is not helping, the plan changes — including stopping.